Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.
Cyber insurers are raising the bar on security. Learn what underwriting trends reveal about organizational resilience and how leaders can prepare.
Colleges face rising fraud from “ghost students.” Learn how to detect fake enrollments, strengthen controls and protect aid funds.
Costs are climbing across health care supply chains. Learn which areas face the most pressure and how to plan with confidence.
Health care providers face rising risks in privacy, AI and HIPAA enforcement. Find out what hospitals can do now to strengthen compliance efforts.
Misaligned controls waste time and create risk. Learn how to rightsize your control environment for clarity, efficiency and impact.
As risk evolves, life science companies must adapt valuation methods. Learn to better align risk, value and strategy in your decision-making process.
FY 2026 ACA enrollment growth may impact health care valuations. Learn how the shift may shape provider revenue and risk.
The DOJ’s updated compliance guidelines require proactive AI risk management. Take steps to ensure your company meets the standards.
J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.
See how ambulatory surgery centers (ASC) and imaging center valuation multiples compare, revealing key differences, patterns and transaction risk.
Sustainable IT isn’t just an environmental initiative. It’s a strategic lever to cut costs, reduce risk and strengthen long-term business performance.